Evidence map›Paper›PMID 23935405›Full record

ArticlePoint of care2012

The Value of Clinical Needs Assessments for Point-of-Care Diagnostics.

Bernhard H Weigl, Charlotte A Gaydos, Gerald Kost, Fred R Beyette, Stephanie Sabourin, Anne Rompalo, Tala de Los Santos, Jason T McMullan, John Haller

Abstract read
In one paragraph

Article in Point of care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Molecular diagnosis of sepsis: New aspects and recent developments.European journal of microbiology & immunology · 2014
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Bernhard H WeiglTechnology Solutions, Program for Appropriate Technology in Health, Seattle, WA.
Charlotte A Gaydos
Gerald Kost
Fred R Beyette
Stephanie Sabourin
Anne Rompalo
Tala de Los Santos
Jason T McMullan
John Haller
Program for Appropriate Technology in Health · USJohns Hopkins University · USUniversity of Cincinnati · USNational Institute of Biomedical Imaging and Bioengineering · USUniversity of California, Davis · US

Funding

TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Matthew Hamill · 2007 to 2026
$34.6M
TrainingU54EB007954 · NIBIB · UNIVERSITY OF CINCINNATI · PI BEYETTE, FRED RICHARD · 2007 to 2011
$9.4M
TrainingU54EB007949 · NIBIB · PATH · PI TOTTEN, PATRICIA A · 2007 to 2011
$8.6M
Rapid Multipathogen Detection for POCT and National Diaster ReadinessU54EB007959 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KOST, GERALD JOSEPH · 2007 to 2011
$8.5M
NIBIB NIH HHS U54 EB007949NIBIB NIH HHS U54 EB007954NIBIB NIH HHS U54 EB007958NIBIB NIH HHS U54 EB007959
6 · The paper itself

Abstract

Most entrepreneurial ventures fail long before the core technology can be brought to the marketplace because of disconnects in performance and usability measures such as accuracy, cost, complexity, assay stability, and time requirements between technology developers' specifications and needs of the end-users. By going through a clinical needs assessment (CNA) process, developers will gain vital information and a clear focus that will help minimize the risks associated with the development of new technologies available for use within the health care system. This article summarizes best practices of the principal investigators of the National Institute of Biomedical Imaging and Bioengineering point-of-care (POC) centers within the National Institute of Biomedical Imaging and Bioengineering POC Technologies Research Network. Clinical needs assessments are particularly important for product development areas that do not sufficiently benefit from traditional market research, such as grant-funded research and development, new product lines using cutting-edge technologies developed in start-up companies, and products developed through product development partnerships for low-resource settings. The objectives of this article were to (1) highlight the importance of CNAs for development of POC devices, (2) discuss methods applied by POC Technologies Research Network for assessing clinical needs, and (3) provide a road map for future CNAs.

Indexed as

brain traumadisaster medicineglobal healthsexually transmitted infectionsuser needs assessment

Identifiers

PMID23935405
PMCPMC3737000
OpenAlexW1982655530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.